These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7735208)

  • 1. In vivo microdialysis for pharmacokinetic investigations: a plasma protein binding study of valproate in rabbits.
    Nakashima M; Takeuchi N; Hamada M; Matsuyama K; Ichikawa M; Goto S
    Biol Pharm Bull; 1994 Dec; 17(12):1630-4. PubMed ID: 7735208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo microdialysis for the transdermal absorption of valproate in rats.
    Matsuyama K; Nakashima M; Ichikawa M; Yano T; Satoh S; Goto S
    Biol Pharm Bull; 1994 Oct; 17(10):1395-8. PubMed ID: 7874063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of drugs over whole blood: I. The transport function of whole blood for valproate.
    Driessen O; Treuren L; Meijer JW
    Ther Drug Monit; 1989; 11(4):384-9. PubMed ID: 2500756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probenecid-inhibitable efflux transport of valproic acid in the brain parenchymal cells of rabbits: a microdialysis study.
    Scism JL; Powers KM; Artru AA; Lewis L; Shen DD
    Brain Res; 2000 Nov; 884(1--2):77-86. PubMed ID: 11082489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of valproate to subdural cerebrospinal fluid, subcutaneous extracellular fluid, and plasma in humans: a microdialysis study.
    Lindberger M; Tomson T; Wallstedt L; Ståhle L
    Epilepsia; 2001 Feb; 42(2):256-61. PubMed ID: 11240599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of total and free valproic acid during monotherapy in infants.
    Herngren L; Lundberg B; Nergårdh A
    J Neurol; 1991 Sep; 238(6):315-9. PubMed ID: 1940980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous microdialysis sampling in awake, freely-moving rats.
    Telting-Diaz M; Scott DO; Lunte CE
    Anal Chem; 1992 Apr; 64(7):806-10. PubMed ID: 1524225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of valproate on the pharmacokinetics of free and total plasma bilirubin in experimental hyperbilirubinemia in guinea pigs.
    Yu HY; Shen YZ
    J Pharm Sci; 1998 Jan; 87(1):21-4. PubMed ID: 9452963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonlinear elimination and hepatic concentration of conjugation-metabolite of valproate in guinea-pigs.
    Yu HY; Wu MS; Shen YZ
    Biopharm Drug Dispos; 1993 May; 14(4):297-312. PubMed ID: 8499581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous absorption of valproic acid and its plasma concentration after application of ointment.
    Ogiso T; Ito Y; Iwaki M; Yamamoto Y; Yamahata T
    J Pharmacobiodyn; 1987 Oct; 10(10):537-42. PubMed ID: 3126287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonlinear binding of valproic acid (VPA) and E-delta 2-valproic acid to rat plasma proteins.
    Semmes RL; Shen DD
    Pharm Res; 1990 May; 7(5):461-7. PubMed ID: 2114617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between valproic acid and carbamazepine: an in vitro study of protein binding.
    Mattson GF; Mattson RH; Cramer JA
    Ther Drug Monit; 1982; 4(2):181-4. PubMed ID: 6808714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates.
    Stapleton SL; Thompson PA; Ou CN; Berg SL; McGuffey L; Gibson B; Blaney SM
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):647-52. PubMed ID: 17541590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of valproic acid in maternal, fetal, and newborn sheep. I: placental transfer, plasma protein binding, and clearance.
    Kumar S; Wong H; Yeung SA; Riggs KW; Abbott FS; Rurak DW
    Drug Metab Dispos; 2000 Jul; 28(7):845-56. PubMed ID: 10859159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition and protein binding of valproic acid in the developing rat.
    Haberer LJ; Pollack GM
    Drug Metab Dispos; 1994; 22(1):113-9. PubMed ID: 8149869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding parameters of valproic acid to serum protein in healthy adults at steady state.
    Kodama Y; Koike Y; Kimoto H; Yasunaga F; Takeyama M; Teraoka I; Fujii I
    Ther Drug Monit; 1992 Feb; 14(1):55-60. PubMed ID: 1546390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of free and total sodium valproate in adolescents and young adults during maintenance therapy.
    Herngren L; Nergårdh A
    J Neurol; 1988 Nov; 235(8):491-5. PubMed ID: 3145327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dose on the kinetic behaviour of valproic acid: modifications in plasma protein binding.
    Gomez MJ; Santos Buelga D; Alonso AC; Garcia MJ; Dominguez-Gil A
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():239-42. PubMed ID: 1820886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical evaluation of hollow type suppositories. V. Preparation of valproic acid suppository and rectal absorption of valproic acid in rabbits.
    Watanabe Y; Tone Y; Nishihara S; Matsumoto M
    J Pharmacobiodyn; 1986 Dec; 9(12):953-61. PubMed ID: 3106614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.